Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
BMC Complementary Medicine and Therapies
Published in: BMC Complementary Medicine and Therapies 1/2018

Open Access 01-12-2018 | Research article

Use of Pinus sylvestris L. (Pinaceae), Origanum vulgare L. (Lamiaceae), and Thymus vulgaris L. (Lamiaceae) essential oils and their main components to enhance itraconazole activity against azole susceptible/not-susceptible Cryptococcus neoformans strains

Authors: Daniela Scalas, Narcisa Mandras, Janira Roana, Roberta Tardugno, Anna Maria Cuffini, Valeria Ghisetti, Stefania Benvenuti, Vivian Tullio

Published in: BMC Complementary Medicine and Therapies | Issue 1/2018

Login to get access

Abstract

Background

Cryptococcal infections, besides being a problem for immunocompromised patients, are occasionally being a problem for immunocompetent patients. In addition, the lower susceptibility of this yeast to azoles is a growing problem in health care. To date, there are very few molecules with any activity towards Cryptococcus neoformans, leading to heightened interest in finding new alternatives or adjuvants to conventional drugs for the treatment of mycosis caused by this yeast. Since the essential oils (EOs) are considered as a potential rich source of bioactive antimicrobial compounds, we evaluated the antifungal activity of Origanum vulgare (oregano), Pinus sylvestris (pine), and Thymus vulgaris (thyme red) EOs, and their components (α-pinene, carvacrol, thymol) compared with fluconazole, itraconazole, and voriconazole, against C.neoformans clinical strains. Then, we investigated the effect of EOs and components in combination with itraconazole.

Methods

EO composition was analysed by Gas chromatography-mass spectrometry (GC-MS). A broth microdilution method was used to evaluate the susceptibility of C.neoformans to azoles, EOs and components. Checkerboard tests, isobolograms and time-kill assays were carried out for combination studies.

Results

Six C.neoformans isolates were susceptible to azoles, while one C.neoformans exhibited a reduced susceptibility to all tested azole drugs. All EOs exerted a good inhibitory activity against all C.neoformans strains. Pine EO was the most effective. Among components, thymol exerted the most remarkable activity. By checkerboard testing and isobolographic analysis, combinations of itraconazole with oregano, pine, or thyme EOs, and carvacrol were found to be synergistic (FICI≤0.5) against azole susceptible C.neoformans. Regarding the azole not susceptible C.neoformans strain, the synergistic effect with itraconazole was observed with thyme EO (chemotype: thymol 26.52%; carvacrol 7.85%), and carvacrol. Time-kill assays confirmed the synergistic effects of itraconazole and oregano or thyme EO against azole susceptible C.neoformans. Binary mixtures of itraconazole/thyme EO or carvacrol yielded additive effects on the azole not susceptible C.neoformans.

Conclusions

Our findings highlight the potential effectiveness of thyme, oregano EOs, and carvacrol as natural and cost-effective adjuvants when used in combination with itraconazole. Identification of EOs exerting these effects could be one of the feasible ways to overcome drug resistance, reducing drug concentration and side effects.
Literature
1.
Gullo FP, Rossi SA, Sardi Jde C, Teodoro VL, Mendes-Giannini MJ, Fusco-Almeida AM. Cryptococcosis: epidemiology, fungal resistance, and new alternatives for treatment. Eur J Clin Microbiol Infect Dis. 2013;32:1377–91.CrossRefPubMed
2.
Mandras N, Roana J, Tullio V, Allizond V, Banche G, Scalas D, Fucale G, Cuffini AM. A case of fluconazole, voriconazole-resistant Cryptococcus neoformans isolated from an immunocompetent patient. J Chemother. 2011;23:379–80.CrossRefPubMed
3.
Elkin I, Rabanel JM, Hildgen P. Influence of hydrophobic dendrimer core structure on the itraconazole encapsulation efficiency. Macromol Chem Phys. 2015;216:2356–67.CrossRef
4.
Mandras N, Roana J, Scalas D, Fucale G, Allizond V, Banche G, Barbui A, Li Vigni N, Newell VA, Cuffini AM, Tullio V. In vitro antifungal activity of fluconazole and voriconazole against non-Candida yeasts and yeast-like fungi clinical isolates. New Microbiol. 2015;38:583–7.PubMed
5.
Cannas S, Usai D, Tardugno R, Benvenuti S, Pellati F, Zanetti S, Molicotti P. Chemical composition, cytotoxicity, antimicrobial and antifungal activity of several essential oils. Nat Prod Res. 2016;30:332–9.CrossRefPubMed
6.
Khan MS, Malik A, Ahmad I. Anti-candidal activity of essential oils alone and in combination with AMB or fluconazole against multi-drug resistant isolates of Candida albicans. Med Mycol. 2012;50:33–42.CrossRefPubMed
7.
Langeveld WT, Veldhuizen EJ, Burt SA. Synergy between essential oil components and antibiotics: a review. Crit Rev Microbiol. 2014;40:76–94.CrossRefPubMed
8.
Mertas A, Garbusińska A, Szliszka E, Jureczko A, Kowalska M, Król W. The influence of tea tree oil (Melaleuca alternifolia) on fluconazole activity against fluconazole-resistant Candida albicans strains. Biomed Res Int. 2015:590470. https://​doi.​org/​10.​1155/​2015/​590470. Epub 2015 Feb 4.
9.
Musiol R, Mrozek-Wilczkiewicz A, Polanski J. Synergy against fungal pathogens: working together is better than working alone. Curr Med Chem. 2014;21:870–93.CrossRefPubMed
10.
Scazzocchio F, Garzoli S, Conti C, Leone C, Renaioli C, Pepi F, Angiolella L. Properties and limits of some essential oils: chemical characterisation, antimicrobial activity, interaction with antibiotics and cytotoxicity. Nat Prod Res. 2015;23:1–10.
11.
Lang G, Bychbauer G. A review on recent research results (2008-2010) on essential oils as antimicrobials and antifungals. A review. Flavour Fragr J. 2012;27:13–39.CrossRef
12.
13.
Palmeira-de-Oliveira A, Salgueiro L, Palmeira-de-Oliveira R, Martinez-de-Oliveira J, Pina-Vaz C, Queiroz JA, Rodrigues AG. Anti-Candida activity of essential oils. Mini Rev Med Chem. 2009;9:1292–305.CrossRefPubMed
14.
Rai M, Paralikar P, Jogee P, Agarkar G, Ingle AP, Derita M, Zacchino S. Synergistic antimicrobial potential of essential oils in combination with nanoparticles: emerging trends and future perspectives. Int J Pharm. 2017;519:67–78.CrossRefPubMed
15.
Tullio V, Nostro A, Mandras N, Dugo P, Banche G, Cannatelli MA, Cuffini AM, Alonzo V, Carlone NA. Antifungal activity of essential oils against filamentous fungi determined by broth microdilution and vapour contact methods. J Appl Microbiol. 2007;102:1544–50.CrossRefPubMed
16.
Nabavi SM, Marchese A, Izadi M, Curti V, Daglia M, Nabavi SF. Plants belonging to the genus Thymus as antibacterial agents: from farm to pharmacy. Food Chem. 2015;173:339–47.CrossRefPubMed
17.
Tullio V, Mandras N, Allizond V, Nostro A, Roana J, Merlino C, Banche G, Scalas D, Cuffini AM. Positive interaction of thyme (red) essential oil with human polymorphonuclear granulocytes in eradicating intracellular Candida albicans. Planta Med. 2012;78:1633–5.CrossRefPubMed
18.
Faria NC, Kim JH, Gonçalves LA, Martins Mde L, Chan KL, Campbell BC. Enhanced activity of antifungal drugs using natural phenolics against yeast strains of Candida and Cryptococcus. Lett Appl Microbiol. 2011;52:506–13.CrossRefPubMed
19.
Fournomiti M, Kimbaris A, Mantzourani I, Plessas S, Theodoridou I, Papaemmanouil V, Kapsiotis I, Panopoulou M, Stavropoulou E, Bezirtzoglou EE, Alexopoulos A. Antimicrobial activity of essential oils of cultivated oregano (Origanum vulgare), sage (Salvia officinalis), and thyme (Thymus vulgaris) against clinical isolates of Escherichia coli, Klebsiella oxytoca, and Klebsiella pneumoniae. Microb Ecol Health Dis. 2015;26:23289. https://​doi.​org/​10.​3402/​mehd.​v26.​23289.PubMed
20.
21.
Khan A, Ahmad A, Ahmad Khan L, Padoa CJ, van Vuuren S, Manzoor N. Effect of two monoterpene phenols on antioxidant defense system in Candida albicans. Microb Pathog. 2015;80:50–6.CrossRefPubMed
22.
de Oliveira Nóbrega R, de Castro Teixeira AP, de Oliveira WA, de Oliveira Lima E, Oliveira Lima I. Investigation of the antifungal activity of carvacrol against strains of Cryptococcus neoformans. Pharm Biol. 2016;54:2591–6.CrossRef
23.
Viollon C, Chaumont JP. Antifungal properties of essential oils and their main components upon Cryptococcus neoformans. Mycopathologia. 1994;128(3):151.CrossRefPubMed
24.
Adams RP. Identification of essential oil components by gas chromatography/mass spectrometry. Fourth Edition. Carol Stream: Allured Publishing Corporation; 2007.
25.
Clinical and Laboratory Standards Institute. Reference Method For Broth Dilution Antifungal Susceptibility Testing Of Yeasts-Third Edition: Approved standard M27-A3. Wayne: CLSI; 2008.
26.
Pfaller MA, Messer SA, Woosley LN, Jones RN, Castanheira M. Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance. J Clin Microbiol. 2013;51:2571–81.CrossRefPubMedPubMedCentral
27.
Mulyaningsih S, Sporer F, Zimmermann S, Reichling J, Wink M. Synergistic properties of the terpenoids aromadendrene and 1,8-cineole from the essential oil of Eucalyptus globulus against antibiotic-susceptible and antibiotic-resistant pathogens. Phytomedicine. 2010;17:1061–6.CrossRefPubMed
28.
Council of Europe 2017. European pharmacopoeia 9th edition: supplement 9.2. Strasbourg: July. p. 2017.
29.
30.
Rivas da Silva AC, Lopes PM, Barros de Azevedo MM, Costa DC, Alviano CS, Alviano DS. Biological activities of α-pinene and β-pinene enantiomers. Molecules. 2012;17:6305–16.CrossRefPubMed
31.
Kumari P, Mishra R, Arora N, Chatrath A, Gangwar R, Roy P, Prasad R. Antifungal and anti-biofilm activity of essential oil active components against Cryptococcus neoformans and Cryptococcus laurentii. Front Microbiol. 2017;8:1–14.CrossRef
32.
Suntres ZE, Coccimiglio J, Alipour M. The bioactivity and toxicological actions of carvacrol. Crit Rev Food Sci Nutr. 2015;55:304–18.CrossRefPubMed
33.
García DA, Bujons J, Vale C, Suñol C. Allosteric positive interaction of thymol with the GABA(a) receptor in primary cultures of mouse cortical neurons. Neuropharmacology. 2006;50:25–35.CrossRefPubMed
34.
Zaribnicky T, Bousova I, Ambroz M, Skalova L. Hepatotoxicity of monoterpenes and sesquiterpenes. Arch Toxicol. 2018;92:1–13.CrossRef
35.
Raut JS, Karuppayil SM. A status review on the medicinal properties of essential oils. Ind crops prod. 2014;62:250–64. doi.org/10.1016/j.indcrop.2014.05.055CrossRef
Metadata
Title
Use of Pinus sylvestris L. (Pinaceae), Origanum vulgare L. (Lamiaceae), and Thymus vulgaris L. (Lamiaceae) essential oils and their main components to enhance itraconazole activity against azole susceptible/not-susceptible Cryptococcus neoformans strains
Authors
Daniela Scalas
Narcisa Mandras
Janira Roana
Roberta Tardugno
Anna Maria Cuffini
Valeria Ghisetti
Stefania Benvenuti
Vivian Tullio
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2018
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-018-2219-4

Other articles of this Issue 1/2018

BMC Complementary Medicine and Therapies 1/2018 Go to the issue

Research article

Oleanolic acid attenuates TGF-β1-induced epithelial-mesenchymal transition in NRK-52E cells

Research article

The development of a survey instrument to measure the barriers to the conduct and application of research in complementary and alternative medicine: a Delphi study

Research article

Which risk understandings can be derived from the current disharmonized regulation of complementary and alternative medicine in Europe?

Research article

Antioxidant and Antiapoptotic effect of aqueous extract of Pueraria tuberosa (Roxb. Ex Willd.) DC. On streptozotocin-induced diabetic nephropathy in rats

Research article

Inhibitory effects of Euphorbia supina on Propionibacterium acnes-induced skin inflammation in vitro and in vivo

Research article

Effective antioxidant, antimicrobial and anticancer activities of essential oils of horticultural aromatic crops in northern Egypt